£121.65

Birkhauser Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Price data checked 6 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£122 today · previous high £122 · all-time low £117

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 85 days · 85 data points (no recent data)

Historical
Generating forecast…
£121.65 £116.76 £117.82 £118.89 £119.96 £121.03 £122.10 13 May 2026 03 June 2026 24 June 2026 15 July 2026 05 August 2026

Price Distribution

Price distribution over 85 days • 3 price levels

Days at Price
Current Price
33 days 42 days 10 days · current 0 11 21 32 42 £117 £118 £122 Days at Price

Price Analysis

Most common price: £118 (42 days, 49.4%)

Price range: £117 - £122

Price levels: 3 different prices over 85 days

Description

Chronic viral hepatitis has emerged as one of the most common causes of disease and death worldwide. Because of their unique modes of replication and intimate association with the host immune system, hepatitis B virus (HBV) and hepatitis C virus (HCV) pose challenging problems to scientists in basic and applied research as well as to clinicians engaged in disease management. Although approved antiviral therapy is available for chronic HBV, the emergence of viral resistance provides a rationale for the development of novel chemotherapeutic agents. The lack of a robust cell culture system for HCV replication and a readily accessible small-animal model of HCV infection have hampered the development of antiviral agents for HCV. Neverthe-less, new antiviral agents targeting HCV are now in preclinical and clinical development. This monograph, providing an up-to-date overview of the field of Hepatitis Prevention and Treatment, includes contributions from internationally recognized experts in the field of viral hepatitis, and covers the current state of knowledge and practice regarding the molecular biology, immunology, biochemistry, pharmacology and clinical aspects of chronic HBV and HCV infection. The volume includes salient topics such as: the history and epidemiology of HBV and HCV; recent insights into the molecular mechanisms of viral replication; the host immune response to infection and a discussion of the use (HBV) or potential development (HCV) of vaccines; the current standard of care for chronically-infected patients; and emerging therapies and issues associated with current antiviral treatments. The latest information to researchers and clinicians actively engaged in viral hepatitis research is provided, but also sufficient background and discussion of the literature to benefit the newcomer to the field.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)
97% match

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Birkhauser

£113.77 05 Aug 2026
Hepatitis B Virus and Liver Disease
88% match

Hepatitis B Virus and Liver Disease

Springer

£89.34 08 Aug 2026
Hepadnaviruses: Molecular Biology and Pathogenesis: 168 (Current Topics in Microbiology and Immunology, 168)
87% match

Hepadnaviruses: Molecular Biology and Pathogenesis: 168 (Current Topics in Microbiology and Immunology, 168)

Springer

£76.42 06 Aug 2026
Hepatitis C Virus and Liver Transplantation
83% match

Hepatitis C Virus and Liver Transplantation

Springer

£73.14 06 Aug 2026
Molecular Components of Hepatitis B Virus: 6 (Developments in Molecular Virology, 6)
83% match

Molecular Components of Hepatitis B Virus: 6 (Developments in Molecular Virology, 6)

Springer

£113.76 07 Aug 2026
Therapeutic Potentials of Tenofovir Alafenamide in Hepatitis B
82% match

Therapeutic Potentials of Tenofovir Alafenamide in Hepatitis B

Elsevier

£137.99 07 Aug 2026
HIV and Liver Disease
81% match

HIV and Liver Disease

Springer

£80.67 05 Aug 2026
Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma
81% match

Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

Springer

£78.01 04 Aug 2026
Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune: 157 (Falk Symposium, 157)
81% match

Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune: 157 (Falk Symposium, 157)

Springer

£45.11 04 Aug 2026
Hepatitis B: The Virus, the Disease, and the Vaccine
81% match

Hepatitis B: The Virus, the Disease, and the Vaccine

Springer

£119.87 07 Aug 2026
Hepatitis Delta Virus: 307 (Current Topics in Microbiology and Immunology, 307)
81% match

Hepatitis Delta Virus: 307 (Current Topics in Microbiology and Immunology, 307)

Springer

£108.01 06 Aug 2026
Combination Therapy of AIDS (Milestones in Drug Therapy)
80% match

Combination Therapy of AIDS (Milestones in Drug Therapy)

Birkhauser

£118.48 07 Aug 2026
HMG-CoA Reductase Inhibitors (Milestones in Drug Therapy)
80% match

HMG-CoA Reductase Inhibitors (Milestones in Drug Therapy)

Birkhauser

£76.42 07 Aug 2026
Liver Cirrhosis: Causes, Diagnosis & Treatment (Hepatology Research and Clinical Developments)
79% match

Liver Cirrhosis: Causes, Diagnosis & Treatment (Hepatology Research and Clinical Developments)

£147.99 08 Aug 2026
Combination Therapy of AIDS (Milestones in Drug Therapy)
79% match

Combination Therapy of AIDS (Milestones in Drug Therapy)

Birkhauser

£108.01 06 Aug 2026
Hepatitis Delta Virus (Medical Intelligence Unit)
79% match

Hepatitis Delta Virus (Medical Intelligence Unit)

Springer

£76.42 06 Aug 2026
Advances in Antiviral Drug Design (Volume 4)
79% match

Advances in Antiviral Drug Design (Volume 4)

Elsevier

£53.74 05 Aug 2026
New Concepts of Antiviral Therapy
79% match

New Concepts of Antiviral Therapy

Springer

£77.49 04 Aug 2026
Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)
79% match

Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)

Springer

£71.94 08 Aug 2026
Vaccines for Latent Viral Infections
78% match

Vaccines for Latent Viral Infections

Bentham Science Publishers

£63.41 10 Aug 2026
Acute and Chronic Liver Diseases: Molecular Biology and Clinics: 87 (Falk Symposium, 87)
78% match

Acute and Chronic Liver Diseases: Molecular Biology and Clinics: 87 (Falk Symposium, 87)

Springer

£138.44 08 Aug 2026
Infectious Agents and Cancer
78% match

Infectious Agents and Cancer

Springer

£76.42 06 Aug 2026
Human Antibody Therapeutics For Viral Disease: 317 (Current Topics in Microbiology and Immunology, 317)
78% match

Human Antibody Therapeutics For Viral Disease: 317 (Current Topics in Microbiology and Immunology, 317)

Springer

£108.01 08 Aug 2026
Drug-Induced Liver Toxicity (Methods in Pharmacology and Toxicology)
78% match

Drug-Induced Liver Toxicity (Methods in Pharmacology and Toxicology)

Humana

£88.30 08 Aug 2026